Lytix Biopharma AS (FRA:6BG)
Germany · Delayed Price · Currency is EUR 0.8220
-0.0040 (-0.48%)
At close: Jan 5, 2026
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of €60.69 million as of January 9, 2026. Its market cap has increased by 152.74% in one year.
Market Cap
60.69M
Enterprise Value
53.24M
Revenue
32.17K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.82
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has decreased from 71.47M to 60.69M, a decrease of -15.08%. That is a compound annual growth rate of -3.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 60.69M | 6.24% |
| Dec 30, 2025 | 57.13M | 67.94% |
| Dec 30, 2024 | 34.01M | 95.78% |
| Dec 29, 2023 | 17.37M | -41.17% |
| Dec 30, 2022 | 29.53M | -44.70% |
| Dec 30, 2021 | 53.40M | -25.28% |
| Jun 14, 2021 | 71.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 240.49B |
| Siemens Aktiengesellschaft | 195.73B |
| Allianz SE | 148.37B |
| Deutsche Telekom AG | 134.57B |
| Siemens Energy AG | 105.59B |
| Rheinmetall AG | 84.93B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.21B |
| Deutsche Bank Aktiengesellschaft | 63.34B |